| FPV/r 1400/100 mg + TDF/FTC QD N = 53 | ATV/r 300/100 mg + TDF/FTC QD N = 53 |
---|---|---|
Diarrhea | 28 (53%) | 13 (25%) |
Blood bilirubin increased | 0 | 16 (30%) |
Nausea | 8 (15%) | 6 (11%) |
Rash | 9 (17%) | 5 (9%) |
Fatigue | 6 (11%) | 7 (13%) |
Headache | 5 (9%) | 3 (6%) |
Hyperbilirubinemia | 0 | 8 (15%) |
Cough | 4 (8%) | 3 (6%) |
Nasopharyngitis | 3 (6%) | 4 (8%) |
Upper respiratory tract infection | 2 (4%) | 4 (8%) |
Arthralgia | 0 | 5 (9%) |
Insomnia | 2 (4%) | 3 (6%) |
Ocular icterus | 0 | 5 (9%) |
Syphilis | 5 (9%) | 0 |
Depression | 3 (6%) | 1 (2%) |
Herpes zoster | 1 (2%) | 3 (6%) |
Dizziness | 3 (6%) | 0 |
Jaundice | 0 | 3 (6%) |
Paresthesia | 3 (6%) | 0 |